Search Database

Name

Zydelig

Alternate Names

idelalisib

Abbreviations

None

Category

Chemotherapy

Subcategory

PI3K delta inhibitor

NSC Number

None

Primary Site

None

Histology

Chronic lymphocytic leukemia (CLL)

Remarks

July 23, 2014 FDA approved idelalisib for the treatment of patients with relapsed CLL in combination with rituximab.

Coding

This drug should be coded
Glossary